🇺🇸 FDA
Patent

US 7745418

Compositions and methods for inhibiting viral replication

granted A61PA61P31/14A61P35/00

Quick answer

US patent 7745418 (Compositions and methods for inhibiting viral replication) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P31/14, A61P35/00